Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

Jelena Celutkiene*, Radek Pudil, Teresa Lopez-Fernandez, Julia Grapsa, Petros Nihoyannopoulos, Jutta Bergler-Klein, Alain Cohen-Solal, Dimitrios Farmakis, Carlo Gabriele Tocchetti, Stephan von Haehling, Vassilis Barberis, Frank A. Flachskampf, Indre Ceponiene, Eva Haegler-Laube, Thomas Suter, Tomas Lapinskas, Sanjay Prasad, Rudolf A. de Boer, Kshama Wechalekar, Markus S. AnkerZaza Iakobishvili, Chiara Bucciarelli-Ducci, Jeanette Schulz-Menger, Bernard Cosyns, Oliver Gaemperli, Yury Belenkov, Jean-Sebastien Hulot, Maurizio Galderisi, Patrizio Lancellotti, Jeroen Bax, Thomas H. Marwick, Ovidiu Chioncel, Tiny Jaarsma, Wilfried Mullens, Massimo Piepoli, Thomas Thum, Stephane Heymans, Christian Mueller, Brenda Moura, Frank Ruschitzka, Jose Luis Zamorano, Giuseppe Rosano, Andrew J. S. Coats, Riccardo Asteggiano, Petar Seferovic, Thor Edvardsen, Alexander R. Lyon

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1504-1524
Number of pages21
JournalEuropean journal of heart failure
Volume22
Issue number9
DOIs
Publication statusPublished - Sep 2020

Keywords

  • Imaging
  • Cardio-oncology
  • Cardiotoxicity
  • Heart failure
  • Echocardiography
  • Cardiac magnetic resonance
  • Computed tomography
  • Global longitudinal strain
  • Nuclear imaging
  • SPECKLE-TRACKING ECHOCARDIOGRAPHY
  • GLOBAL LONGITUDINAL STRAIN
  • LEFT-VENTRICULAR FUNCTION
  • MAGNETIC-RESONANCE
  • BREAST-CANCER
  • ANTHRACYCLINE CARDIOTOXICITY
  • CHAMBER QUANTIFICATION
  • MYOCARDIAL STRAIN
  • AMERICAN SOCIETY
  • DIASTOLIC FUNCTION

Cite this